Target intelligence / Profile preview

RNF103-CHMP3 readthrough protein (RNF103-CHMP3)

Target
RNF103-CHMP3
Molecular classification
ESCRT-III complex component, Protein sorting/trafficking factor, Other
01

Overview

RNF103-CHMP3 readthrough protein is a naturally occurring human fusion protein, produced by read-through transcription of the adjacent RNF103 (ring finger protein 103) and CHMP3 (charged multivesicular body protein 3) genes[1][3]. This fusion protein contains sequence and likely functional motifs derived from both parental proteins, with CHMP3 being a notable core component of the endosomal sorting required for transport complex III (ESCRT-III)[2][8]. ESCRT-III is essential for the formation of multivesicular bodies (MVBs), sorting of membrane proteins for lysosomal degradation, the terminal events of cytokinesis, and the budding of some enveloped viruses, including HIV-1[2][4][6][8]. Loss or dysregulation of this pathway is associated with diseases such as frontotemporal dementia, amyotrophic lateral sclerosis, cancer (via growth factor receptor regulation), and infection[2][4]. While no approved therapeutics currently target the RNF103-CHMP3 fusion, its function within ESCRT-III marks it as a potential drug target for modulating intracellular trafficking and membrane dynamics in disease contexts[4].

Other names
CGI149CHMP3NEDFRNF103-VPS24VPS24hVps24RNF103-CHMP3 proteinCharged multivesicular body protein 3Chromatin-modifying protein 3Neuroendocrine differentiation factorRNF103-CHMP3 read-throughRNF103-VPS24 readthroughVacuolar protein sorting-associated protein 24
02

Biological functions

Endosomal sortingMultivesicular body (MVB) biogenesisMembrane protein degradationCytokinesisViral budding (e.g., HIV-1)Regulation of cell death (isoform-dependent)
03

Disease associations

Neurodegenerative diseaseInfection (HIV, other enveloped viruses)Cancer (through trafficking and degradation of growth factor receptors)Other
04

Safety considerations

Potential for disrupting essential endosomal/lysosomal traffickingPossible impacts on neuronal and immune function if broadly inhibited

Beyond the preview

Go deeper on RNF103-CHMP3 readthrough protein (RNF103-CHMP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNF103-CHMP3 readthrough protein (RNF103-CHMP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call